ERBB2 and breast carcinoma: However, there has been no standard or guideline regarding how many samples are necessary for pathological assessment of biomarkers of breast cancer, including surface hormone receptors, the estrogen receptor (ER) and the progesterone receptor (PgR), and the human epidermal growth factor receptor 2 (HER2).